Info on Radioactive Drug Research Sent to OMB
04/30/2014
Federal Register Notice: FDA’s proposed collection of information, “Radioactive Drug Research Committees,” has b...
FDA Announces Hearing Opportunity on Allergenic Extract
04/30/2014
Review Period Set for Brilinta
04/30/2014
Comments Sought on Feedback on FDA Service
04/29/2014
Federal Register Notice: FDA is seeking comments on a collection of information, “Generic Clearance for the Collection of Qu...
Workshop on Pediatric Clinical Investigator Training
04/29/2014
Info on Pharmacogenomic Data Guidance Sent to OMB
04/28/2014
Comments Sought on DTC Drug Ad Study
04/21/2014
Federal Register Notice: FDA is seeking public comment on a proposed collection of information by the agency on a study, “Ri...
Panel to Discuss AstraZeneca NDA for Ovarian Cancer
04/21/2014
Federal Register Notice: FDA’s Oncologic Drugs Advisory Committee will meet 6/25 from 8:30 a.m. to 3:30 p.m. at the FDA Whit...
Workshop on Next-Generation Sequencing
04/21/2014
Federal Register Notice: FDA will hold a public workshop 9/24-25 entitled “Next-Generation Sequencing (NGS) Technology, Data...
FDA Seeks Pharmacy Compounding Panel Selectors
04/21/2014
Federal Register Notice: FDA is reopening until 5/5 the period for industry organizations to apply to represent, in a non-voting c...
